Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Jenna K. Bardwell
Lurie Children's Hospital of Chicago
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
106
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
The Late Effects after High-Risk Neuroblastoma (LEAHRN) Study - A Report from the Children's Oncology Group
Number of pages: 33
Posted: 16 May 2025
Tara O. Henderson
, Jenna K. Bardwell,
Pei-Chi Kao
,
Paul Nathan
,
Wendy Landier
,
Sogol Mostoufi-Moab
,
Tara M. Brinkman
,
Fiona Schulte
,
Julie R. Park
,
Saro Armenian
,
Arlene Naranjo
,
Meera Subramaniam
,
Araz Marachellian
,
Sharon J. Diskin
,
Wendy B. London
and
Lisa R. Diller
Lurie Children's Hospital of Chicago, Lurie Children's Hospital of Chicago, Harvard University - Dana-Farber Cancer Institute, The Hospital for Sick Children - Division of Hematology/Oncology, University of Alabama at Birmingham - Institute for Cancer Outcomes and Survivorship, Children’s Hospital of Philadelphia, St. Jude Children’s Research Hospital, University of Calgary, St. Jude Children’s Research Hospital, City of Hope - Department of Population Sciences, The Children's Oncology Group (COG) Statistics and Data Center (SDC) - Department of Biostatistics, Harvard University - Dana-Farber Cancer Institute, University of Southern California - Children’s Hospital Los Angeles, University of Pennsylvania - Division of Oncology, Harvard University - Dana-Farber Cancer Institute and Harvard University - Dana-Farber Cancer Institute
Downloads
106
(659,652)
View PDF
Download
Abstract:
Childhood cancer, Neuroblastoma, Survivorship, Late effects, Long-term toxicity
Feedback